ISPOR 2026 Home
Register   Program Guide
  • About
    • Why Attend
    • Volunteer Opportunities
    • Registration Information
    • Marketing Kit
      • ISPOR 2026 Badges
      • #ISPORAnnual—Tweet, Post, Share!
      • Spread the Word
    • Press
    • Attendee Resources
    • Mobile App
    • Networking Opportunities
    • Attendee Guide
    • Social Feed
    • News Center
  • Program
    • Program
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Plenary Sessions
  • Short Courses
    • ISPOR 2026 Short Courses
    • View All Short Courses
  • Presenter Information
    • Speaker Resources
    • Poster Resources
  • Exhibits & Sponsorship
    • Exhibitor Resources
    • Exhibitor Directory
    • Sponsors
    • Affiliate Events
    • Media Partners
  • Hotel & Travel
    • Hotel Information
    • Venue Information
    • Discover Philadelphia
large-circle

ISPOR 2026

Sunday, May 17 - Wednesday, May 20

  • Home
  • Events
  • Upcoming Conferences & Events
  • ISPOR 2026
  • Program
  • Program
  • Presentation
  • GENERIC ENTRY AND THE EARLY IMPACT ON U.S. PHARMACEUTICAL SPENDING

    Mar 18, 2026, 21:38 PM
  • FINANCIAL COSTS OF PROVIDING ORAL PRE- AND POST-EXPOSURE PROPHYLAXIS VIA PHARMACIES IN KENYA

    Mar 18, 2026, 21:38 PM
  • IMPACT OF LIPID-LOWERING THERAPIES ON TRIGLYCERIDE LEVELS IN US PATIENTS WITH ASCVD IN THE REAL-WORLD

    Mar 18, 2026, 21:38 PM
  • ATTRIBUTE MINING FOR DISCRETE CHOICE EXPERIMENTS ACROSS DISEASES USING GEN-AI: REPLICATION AND VALIDATION OBJECTIVES

    Mar 18, 2026, 21:38 PM
  • REAL-WORLD DOSING AND DISCONTINUATION OF HYPERTENSION THERAPIES: INSIGHTS FROM A NATIONAL PHARMACY DATABASE

    Mar 18, 2026, 21:38 PM
  • VALIDATION OF THE HEPARIN-INDUCED THROMBOCYTOPENIA DIAGNOSIS CODE USING A LARGE-SCALE ELECTRONIC HEALTH RECORD DATABASE

    Mar 18, 2026, 21:38 PM
  • TARGETED LITERATURE REVIEW TO IDENTIFY US CLAIMS-BASED ALGORITHMS FOR ALZHEIMER’S DISEASE

    Mar 18, 2026, 21:38 PM
  • INCREASING EFFICIENCY OF SYSTEMATIC LITERATURE REVIEWS: ARE MULTIPLE DATABASES NECESSARY?

    Mar 18, 2026, 21:38 PM
  • THE PATTERNS OF COUPON OFFSETS IN GLUCAGON-LIKE PEPTIDE AGONIST USE:EVIDENCE FROM NATIONAL, ALL-PAYER PHARMACY CLAIMS

    Mar 18, 2026, 21:38 PM
  • COMPARATIVE RISK OF PSYCHIATRIC OUTCOMES WITH GLP-1RAS ACROSS METABOLIC INDICATIONS: A POPULATION-BASED RETROSPECTIVE COHORT STUDY

    Mar 18, 2026, 21:38 PM
  • MULTI-INDICATION BUDGET IMPACT ANALYSIS OF SUBCUTANEOUS IGPRO20 PRE-FILLED SYRINGES FOR THE TREATMENT OF PID, SID, AND CIDP IN ITALY

    Mar 18, 2026, 21:38 PM
  • EFFECT OF WOUND EXUDATE SEVERITY ON TIME TO COMPLETE HEALING IN DIABETIC FOOT ULCERS: A REAL-WORLD LONGITUDINAL ANALYSIS (EXACT STUDY)

    Mar 18, 2026, 21:38 PM
  • INTEGRATION OF PATIENT-REPORTED OUTCOME MEASURES IN LOWER URINARY TRACT SYMPTOMS ATTRIBUTED TO BENIGN PROSTATIC HYPERPLASIA (LUTS/BPH) CARE: QUALITATIVE INSIGHTS FOR IMPLEMENTATION STRATEGIES

    Mar 18, 2026, 21:38 PM
  • EARLY PATTERNS IN SECOND ORPHAN DRUG DESIGNATIONS FOLLOWING EXPANSION OF THE ORPHAN DRUG EXCLUSION

    Mar 18, 2026, 21:38 PM
  • A SEQUENTIAL MATCHING APPROACH TO ADDRESS IMMORTAL TIME BIAS: APPLICATION TO THE MGUS STUDY

    Mar 18, 2026, 21:38 PM
  • PREDICTORS OF PATIENT-DIRECTED DISCHARGE AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER

    Mar 18, 2026, 21:38 PM
  • A COST CALCULATOR FOR ESTIMATING DIRECT MEDICAL COST AVOIDANCE FROM SECOND-LINE SELADELPAR USE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

    Mar 18, 2026, 21:38 PM
  • CHANGING THE RULES OF THE GAME: AN AI-DRIVEN GAME-THEORETIC ANALYSIS OF THE CAUSAL DRIVERS IN EARLY-ONSET MALIGNANCY

    Mar 18, 2026, 21:38 PM
  • BETA-BLOCKER USE AND BREAST CANCER OUTCOMES: A SCOPING REVIEW

    Mar 18, 2026, 21:38 PM
  • COMPARATIVE VALUE-BASED PERFORMANCE ACROSS NUTRITION, PSYCHOLOGY, AND PHYSIOTHERAPY CARE PATHWAYS USING PATIENT-REPORTED OUTCOMES, EXPERIENCE, AND COST DATA

    Mar 18, 2026, 21:38 PM
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88 (current)
  • 89
  • 90
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group